Search the collection

53 results for Risperidone+-+economics

Sort by:

Sort by

Limit results to:

20 per page

53 results for Risperidone+-+economics

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 21
ArticlesPeer ReviewedFull Text
Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia: A 12- and 24-month follow-up from the e-STAR database in Spain
Author / Creator:Olivares, José M. ; Rodriguez-Martinez, Alfonso ; Burón, José A. ; Alonso-Escolano, David ; Rodriguez-Morales, Alexander
Publisher:Cham: Springer International Publishing
Journal title:Applied health economics and health policy, 2008-01, Vol.6 (1), p.41-53
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 22
ArticlesPeer ReviewedFull Text
The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden
Author / Creator:Willis, Michael ; Svensson, Marianne ; Löthgren, Mickael ; Eriksson, Bo ; Berntsson, Anders ; Persson, Ulf
Publisher:Berlin/Heidelberg: Springer
Journal title:The European journal of health economics, 2010-12, Vol.11 (6), p.585-594
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 23
ArticlesPeer ReviewedFull Text
Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA
Author / Creator:Edwards, Natalie Christine ; Locklear, Julie C. ; Rupnow, Marcia F. T. ; Diamond, Ronald J.
Publisher:New Zealand
Journal title:PharmacoEconomics, 2005-01, Vol.23 (S1), p.75-89
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 24
ArticlesPeer ReviewedFull Text
Comparative Effectiveness of Long-Acting Risperidone in New Zealand: A Report of Resource Utilization and Costs in a 12-Month Mirror-Image Analysis
Author / Creator:Carswell, Christopher ; Wheeler, Amanda ; Vanderpyl, Jane ; Robinson, Elizabeth
Publisher:Cham: Springer International Publishing
Journal title:Clinical drug investigation, 2010-11, Vol.30 (11), p.777-787
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 25
ArticlesPeer ReviewedFull Text
Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia
Author / Creator:Rosenheck, Robert A ; Krystal, John H ; Lew, Robert ; Barnett, Paul G ; Thwin, Soe Soe ; Fiore, Louis ; Valley, Danielle ; Huang, Grant D ; Neal, Carla ; Vertrees, Julia E ; Liang, Matthew H
Publisher:London, England: SAGE Publications
Journal title:Clinical trials (London, England), 2011-04, Vol.8 (2), p.196-204
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 26
ArticlesPeer ReviewedFull Text
Cost effectiveness of long-acting risperidone in Sweden
Author / Creator:Hensen, Marja ; Heeg, Bart ; Löthgren, Mickael ; van Hout, Ben
Publisher:Cham: Springer International Publishing
Journal title:Applied health economics and health policy, 2010-09, Vol.8 (5), p.327-341
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 27
ArticlesPeer ReviewedFull Text
Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US
Author / Creator:Edwards, Natalie C ; Rupnow, Marcia F T ; Pashos, Chris L ; Botteman, Marc F ; Diamond, Ronald J
Publisher:Auckland: Adis International
Journal title:PharmacoEconomics, 2005-01, Vol.23 (3), p.299-314
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 28
ArticlesPeer ReviewedFull Text
Perspectives on the bioequivalence and therapeutic equivalence of generic formulations: An overview of the landscape
Author / Creator:Perry, Richard, PharmD
Publisher:United States: EM Inc USA
Journal title:Clinical therapeutics, 2010-09, Vol.32 (10), p.1796-1797
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 29
ArticlesPeer ReviewedFull Text
A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda
Author / Creator:Lubinga, Solomon J. ; Mutamba, Byamah B. ; Nganizi, Angelo ; Babigumira, Joseph B.
Publisher:Cham: Springer International Publishing
Journal title:Applied health economics and health policy, 2015-10, Vol.13 (5), p.493-506
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 30
ArticlesPeer ReviewedFull Text
Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data
Author / Creator:Frey, Simon ; Linder, Roland ; Juckel, Georg ; Stargardt, Tom
Publisher:Berlin/Heidelberg: Springer
Journal title:The European journal of health economics, 2014-03, Vol.15 (2), p.133-142
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 31
ArticlesPeer ReviewedFull Text
Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness
Author / Creator:Keith, Samuel
Publisher:England: Taylor & Francis
Journal title:Expert review of neurotherapeutics, 2009-01, Vol.9 (1), p.9-31
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 32
ArticlesPeer ReviewedFull Text
Generic atypical antipsychotic drugs in Belgium: their influence and implications
Author / Creator:Godman, Brian ; De Bruyn, Kristien ; Miranda, Jamilette ; Raschi, Emanuel ; Bennie, Marion ; Barbui, Corrado ; Simoens, Steven
Publisher:England: Future Medicine Ltd
Journal title:Journal of comparative effectiveness research, 2013-11, Vol.2 (6), p.551-561
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 33
ArticlesPeer ReviewedFull Text
The cost associated with administering risperidone long-acting injections in the Australian community
Author / Creator:Dalton, Andrew ; Lambert, Tim ; Schrover, Rudolf ; Hertel, Judy ; Smith, Dell Kingsford
Publisher:England: BioMed Central Ltd
Journal title:BMC health services research, 2011-09, Vol.11 (1), p.236-236, Article 236
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 34
ArticlesPeer ReviewedFull Text
The cost-effectiveness of risperidone long-acting injection in the treatment of schizophrenia
Author / Creator:Chue, Pierre ; Chue, James
Publisher:London: Taylor & Francis
Journal title:Expert review of pharmacoeconomics & outcomes research, 2012-06, Vol.12 (3), p.259-269
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 35
ArticlesPeer ReviewedFull Text
Influence of patient co-payments on atypical antipsychotic choice in Poland: Implications once generic atypicals are available
Author / Creator:Wladysiuk, Magda ; Araszkiewicz, Aleksander ; Godman, Brian ; Szabert, Katarzyna ; Barbui, Corrado ; Haycox, Alan
Publisher:Cham: Springer International Publishing
Journal title:Applied health economics and health policy, 2011-03, Vol.9 (2), p.101-110
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 36
ArticlesPeer ReviewedFull Text
Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany
Author / Creator:Laux, Gerd ; Heeg, Bart M. S. ; van Hout, Ben A. ; Mehnert, Angelika
Publisher:New Zealand
Journal title:PharmacoEconomics, 2005-01, Vol.23 (S1), p.49-61
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 37
ArticlesPeer ReviewedFull Text
Risperidone: A Review of its Use in the Treatment of Bipolar Mania
Author / Creator:Fenton, Caroline ; Scott, Lesley J
Publisher:Hong Kong: Adis International
Journal title:CNS drugs, 2005-01, Vol.19 (5), p.429-444
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 38
ArticlesPeer ReviewedFull Text
Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis
Author / Creator:De Graeve, Diana ; Smet, Ann ; Mehnert, Angelika ; Caleo, Sue ; Miadi-Fargier, Houda ; Mosqueda, Guillermo Jasso ; Lecompte, Damien ; Peuskens, Joseph
Publisher:New Zealand
Journal title:PharmacoEconomics, 2005-01, Vol.23 (S1), p.35-47
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 39
ArticlesPeer ReviewedFull Text
Cost-effectiveness and budget impact of long-acting risperidone in Portugal: a modeling exercise
Author / Creator:Heeg, B. M. S. ; Antunes, J. ; Figueira, M. L. ; Jara, J. M. ; Marques Teixeira, J. ; Palha, A. P. ; Vaz Serra, A. ; Buskens, E. ; Caleo, S. ; Gouveia-Pinto, C. ; Van Hout, B. A.
Publisher:England: Informa UK Ltd
Journal title:Current medical research and opinion, 2008-02, Vol.24 (2), p.349-358
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 40
ArticlesPeer ReviewedFull Text
Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada
Author / Creator:Chue, P. S. ; Heeg, Bart M. S. ; Buskens, Erik ; van Hout, Ben A.
Publisher:New Zealand
Journal title:PharmacoEconomics, 2005-01, Vol.23 (S1), p.62-74
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 21 to 40 of 53 results

Export record to excel

Export this record

Export record to excel

Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia: A 12- and 24-month follow-up from the e-STAR database in Spain

Export this record

Export record to excel

The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden

Export this record

Export record to excel

Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA

Export this record

Export record to excel

Comparative Effectiveness of Long-Acting Risperidone in New Zealand: A Report of Resource Utilization and Costs in a 12-Month Mirror-Image Analysis

Export this record

Export record to excel

Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia

Export this record

Export record to excel

Cost effectiveness of long-acting risperidone in Sweden

Export this record

Export record to excel

Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US

Export this record

Export record to excel

Perspectives on the bioequivalence and therapeutic equivalence of generic formulations: An overview of the landscape

Export this record

Export record to excel

A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda

Export this record

Export record to excel

Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data

Export this record

Export record to excel

Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness

Export this record

Export record to excel

Generic atypical antipsychotic drugs in Belgium: their influence and implications

Export this record

Export record to excel

The cost associated with administering risperidone long-acting injections in the Australian community

Export this record

Export record to excel

The cost-effectiveness of risperidone long-acting injection in the treatment of schizophrenia

Export this record

Export record to excel

Influence of patient co-payments on atypical antipsychotic choice in Poland: Implications once generic atypicals are available

Export this record

Export record to excel

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany

Export this record

Export record to excel

Risperidone: A Review of its Use in the Treatment of Bipolar Mania

Export this record

Export record to excel

Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis

Export this record

Export record to excel

Cost-effectiveness and budget impact of long-acting risperidone in Portugal: a modeling exercise

Export this record

Export record to excel

Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada

Refine your search